Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Sanidad Militar
versión impresa ISSN 1887-8571
Resumen
GRANDA-LOBATO, P; CORREA-PEREZ, A; SILVA-CUEVAS, M y GARCIA-LUQUE, A. Positive assessment of drugs: from April, May and June of 2022. Sanid. Mil. [online]. 2022, vol.78, n.3, pp.182-187. Epub 30-Ene-2023. ISSN 1887-8571. https://dx.doi.org/0.4321/s1887-857120220003000010.
The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public from April to June of 2022, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.
Palabras clave : Asciminib (Scemblix®); Budesonide (Kinpeygo®); Capmatinib (Travecta®); Efgartigimod Alfa (Vyvgart®); Eladocagene Exuparvovec (Upstaza®); Eptacog Beta Activated (Cevenfacta®); Birch Bark Extract (Fisulvez®); Lasmiditan (Rayvow®); Lenacapavir (Sunlenca®); Melphalan Flufenamide (Pepaxti®); Mosunetuzumab (Lunsumio®); Olipudase Alfa (Xenpozyme®); Lonafarnib (Zokinvy®); COVID-19 vaccine (inactivated, adjuvanted, adsorbed) (Valneva®); Valoctocogene Roxaparvovec (Roctavian®).